Clinical trialNCT02211300UnknownInterventional

MANAGE Automated Glucose Monitoring

SponsorOptiScan Biomedical CorporationEnrollment230ICU/CCU Patients Requiring Blood Glucose Monitoring

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to demonstrate that the OptiScanner® is safe and can provide accurate blood glucose levels in critically ill subjects. Accuracy Hypothesis: The assessment of blood glucose level that results from the OptiScanner is comparable to the YSI 2300 STAT Plus™ Glucose and Lactate Analyzer ("YSI Analyzer"; YSI Life Sciences, Yellow Springs, OH). Safety Hypothesis: The OptiScanner has an acceptable risk/benefit profile for a system that can provide repeated automated blood glucose levels for critically ill subjects.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Anthony Furnary, MD
Providence St. Vincents Medical Center
Principal Investigator
clinicaltrials.gov ↗
Grant V Bochicchio, MD, MPH
Washington University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Linda Moore, MD
Hermann Memorial Hospital
Principal Investigator
clinicaltrials.gov ↗
Stanley A Nasraway, MD
Tufts Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Tufts Medical Center
Boston, Massachusetts, United States
Stanley Nasraway, MD
Recruiting
Washington University School of Medicine
St Louis, Missouri, United States
Grant Bochicchio, MD
Recruiting
Providence Heart and Vascular Institute
Portland, Oregon, United States
Anthony Furnary, MD
Recruiting
Hermann Memorial Hospital
Houston, Texas, United States
Laura Moore, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Apr 2014
Primary completion: 30 Sept 2015
Completion: 31 Dec 2015
Last update posted: 29 Jun 2015
Registered enrollment: 230
Registry id: NCT02211300

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.